Literature DB >> 15819681

Efficacy of Epstein-Barr virus removal by leukoreduction of red blood cells.

Lirong Qu1, Shushen Xu, David Rowe, Darrell Triulzi.   

Abstract

BACKGROUND: Epstein-Barr virus (EBV) infection results in life-long carriage of latent virus in B lymphocytes in the majority of the adult population, including blood donors. The removal of EBV from red blood cell (RBC) components by leukoreduction was assessed. STUDY DESIGN AND METHODS: Sixteen randomly selected fresh AS-5 units were leukoreduced by filtration. B lymphocytes from preleukoreduction specimens and mononuclear cells (MNCs) from postleukoreduction specimens were assayed for EBV DNA with sensitive real-time polymerase chain reaction (PCR).
RESULTS: EBV genomes were detected in CD19+ B cells in 14 of 16 preleukoreduced RBC units. EBV genomic copy number in the units ranged from 0.18 to 96.84 per 10(5) B lymphocytes representing approximately 135 to 72,630 total EBV genomes per bag. Leukoreduction rendered all but one unit EBV-negative by PCR. The lone PCR-positive unit after leukoreduction amplified 1.2 EBV genome copies from MNCs recovered from the entire unit of leukoreduced RBCs; this unit had the highest EBV viral load before leukoreduction (72,630 EBV genomes).
CONCLUSIONS: These results indicate that a 4-log reduction of EBV genomic copy number can be achieved with leukoreduction of RBC units and renders most RBC units EBV-negative by sensitive PCR.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15819681     DOI: 10.1111/j.0041-1132.2005.04303.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  5 in total

Review 1.  Leucoreduction of blood components: an effective way to increase blood safety?

Authors:  Maria Bianchi; Stefania Vaglio; Simonetta Pupella; Giuseppe Marano; Giuseppina Facco; Giancarlo M Liumbruno; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2015-12-16       Impact factor: 3.443

2.  Epstein-Barr virus infection after unrelated cord blood transplantation: reactivation or reinfection?

Authors:  Keisei Kawa; Akihisa Sawada; Maho Koyama; Masami Inoue
Journal:  Int J Hematol       Date:  2007-04       Impact factor: 2.490

3.  Role of Leukoreduction of Packed Red Blood Cell Units in Trauma Patients: A Review.

Authors:  Young Kim; Brent T Xia; Alex L Chang; Timothy A Pritts
Journal:  Int J Hematol Res       Date:  2016-06-27

4.  Effects of storage and leukoreduction on lymphocytes and Epstein-Barr virus genomes in platelet concentrates.

Authors:  Lirong Qu; David T Rowe; Albert D Donnenberg; Deborah L Griffin; Darrell J Triulzi
Journal:  Transfusion       Date:  2009-08       Impact factor: 3.157

5.  [Evolution of techniques for preparation of labile blood products (LBP): pathogen inactivation in LBP].

Authors:  C Naegelen; H Isola; D Dernis; J-P Maurel; R Tardivel; S Bois; C Vignoli; J-P Cazenave
Journal:  Transfus Clin Biol       Date:  2009-05-13       Impact factor: 1.406

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.